Jupiter Asset Management’s Harvard Bioscience HBIO Stock Holding History

Jupiter Asset Management’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-33,566	Closed	-$856K	–	216
2017 Q2	$856K	Sell	33,566 -44,436	-57%	-$1.1M	0.03%	209
2017 Q1	$2.03M	Sell	78,002 -7,074	-8%	-$204K	0.07%	200
2016 Q4	$2.6M	Sell	85,076 -214	-0.3%	-$5.44K	0.1%	184
2016 Q3	$2.32M	Sell	85,290 -2,135	-2%	-$59.3K	0.09%	186
2016 Q2	$2.5M	Sell	87,425 -2,303	-3%	-$73.3K	0.1%	182
2016 Q1	$2.71M	Sell	89,728 -870	-1%	-$24.7K	0.1%	179
2015 Q4	$3.14M	Hold	90,598	–	–	0.12%	166
2015 Q3	$3.42M	Buy	90,598 +7,626	+9%	+$355K	0.13%	156
2015 Q2	$4.73M	Sell	82,972 -5,040	-6%	-$287K	0.17%	151
2015 Q1	$5.12M	Sell	88,012 -17,070	-16%	-$917K	0.18%	151
2014 Q4	$5.96M	Buy	105,082 +4,700	+5%	+$224K	0.19%	143
2014 Q3	$4.11M	Buy	100,382 +1,280	+1%	+$58.9K	0.14%	171
2014 Q2	$4.51M	Buy	99,102 +61,440	+163%	+$2.58M	0.14%	181
2014 Q1	$1.78M	Buy	+37,662	New	+$1.71M	0.06%	208

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPC

Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Foundry Partners Minneapolis, Minnesota $1.89B AUM 9.84% 1-Year Est. Return

Jupiter Asset Management's HBIO Position: Q3 2017 in Review

Jupiter Asset Management sold out of Harvard Bioscience (HBIO) in Q3 2017, closing a stake of 33,566 shares — an estimated $856K sold.

Jupiter Asset Management first reported a position in HBIO in Q1 2014 and held it in 14 quarters. The position peaked at $5.96M in Q4 2014. 53 funds tracked by Wall St. Rank hold HBIO as of Q3 2017.

Jupiter Asset Management reported no remaining Harvard Bioscience position as of Q3 2017 after selling out during the quarter.
Jupiter Asset Management sold 33,566 Harvard Bioscience shares in Q3 2017, an estimated $856K.
Jupiter Asset Management first reported a position in Harvard Bioscience in Q1 2014 and held it in 14 quarters.
Jupiter Asset Management's Harvard Bioscience position peaked at $5.96M in Q4 2014.
53 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2017.

Based on Jupiter Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.